Literature DB >> 7042727

Adjusted survival curve estimation using covariates.

R W Makuch.   

Abstract

Covariate adjustment techniques, such as Cox's proportional hazard model, are used frequently in the analysis of clinical trials to compare survival of patients in two or more treatment groups. A visual display of survival curves for each treatment group is often plotted using the Kaplan-Meier method even though statistical adjustment techniques are used in making treatment comparisons. As a result, a statistically significant difference may be achieved between treatment groups although the survival curves appear similar. One solution to this problem was suggested by Hankey and Myers who derived survival curves accounting for patient characteristics based on Mantel's statistic. In this paper a method for estimating survival curves with covariates is described for use with Cox's model. An example is provided to illustrate its usefulness in providing to the medical audience a graphical display which is consistent with the achieved level of statistical significance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042727     DOI: 10.1016/0021-9681(82)90058-3

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  56 in total

1.  Assessing effects on long-term survival after early termination of randomized trials.

Authors:  Y Shen; T R Fleming
Journal:  Lifetime Data Anal       Date:  1999       Impact factor: 1.588

2.  Diffusing capacity predicts long-term survival after lung resection for cancer.

Authors:  Mark K Ferguson; James J Dignam; Juned Siddique; Wickii T Vigneswaran; Amy D Celauro
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-24       Impact factor: 4.191

3.  Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.

Authors:  Florian C Bonke; Ewan Donnachie; Antonius Schneider; Michael Mehring
Journal:  Diabetologia       Date:  2015-10-30       Impact factor: 10.122

4.  Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

Authors:  Mohamed L Sorror; Rainer F Storb; Brenda M Sandmaier; Richard T Maziarz; Michael A Pulsipher; Michael B Maris; Smita Bhatia; Fabiana Ostronoff; H Joachim Deeg; Karen L Syrjala; Elihu Estey; David G Maloney; Frederick R Appelbaum; Paul J Martin; Barry E Storer
Journal:  J Clin Oncol       Date:  2014-08-25       Impact factor: 44.544

5.  Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.

Authors:  Yoshikuni Kawaguchi; Scott Kopetz; Timothy E Newhook; Mario De Bellis; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Clin Cancer Res       Date:  2019-06-20       Impact factor: 12.531

6.  Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival.

Authors:  Tsuyoshi Hamada; Chen Yuan; Shuji Ogino; Brian M Wolpin; Ying Bao; Mingfeng Zhang; Natalia Khalaf; Ana Babic; Vicente Morales-Oyarvide; Barbara B Cochrane; J Michael Gaziano; Edward L Giovannucci; Peter Kraft; JoAnn E Manson; Kimmie Ng; Jonathan A Nowak; Thomas E Rohan; Howard D Sesso; Meir J Stampfer; Laufey T Amundadottir; Charles S Fuchs; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-19       Impact factor: 4.254

7.  Adjusting and comparing survival curves by means of an additive risk model.

Authors:  P H Zahl; O O Aalen
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

8.  A pooled analysis of waist circumference and mortality in 650,000 adults.

Authors:  James R Cerhan; Steven C Moore; Eric J Jacobs; Cari M Kitahara; Philip S Rosenberg; Hans-Olov Adami; Jon O Ebbert; Dallas R English; Susan M Gapstur; Graham G Giles; Pamela L Horn-Ross; Yikyung Park; Alpa V Patel; Kim Robien; Elisabete Weiderpass; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; Patricia Hartge; Leslie Bernstein; Amy Berrington de Gonzalez
Journal:  Mayo Clin Proc       Date:  2014-03       Impact factor: 7.616

9.  Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes.

Authors:  Matthew J O'Brien; Susan L Karam; Amisha Wallia; Raymond H Kang; Andrew J Cooper; Nicola Lancki; Margaret R Moran; David T Liss; Theodore A Prospect; Ronald T Ackermann
Journal:  JAMA Netw Open       Date:  2018-12-07

10.  Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial.

Authors:  Rober C Welsh; Luc Sauriol; Zugui Zhang; Paul Kolm; Willian S Weintraub; Pierre Theroux
Journal:  Can J Cardiol       Date:  2009-12       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.